Recurrence-free survival was numerically higher with adjuvant pembrolizumab, but difference was ...
80 percent of adult patients with stage III/IV resectable melanoma remained ...
One-time surgical application of prademagene zamikeracel improves wound healing and pain ...
Zevaskyn is the first and only autologous cell-based gene therapy for ...